Laboratory studies examining the pathogenetic role of JAK2 mutations are highlighted by its origin at the stem cell level and the demonstration of heightened JAK-STAT activation and induction of mutant JAK2-driven PV phenotype in mice [5, 12, 13]. This evidence concerns the gene JAK2 and acquired polycythemia vera.